|
|
|
40
|
B1511
|
PRADAX 75MG TAB (BOE/STO) DABIGATRAN
|
DABIGATRAN
|
PRADAX
|
3X10
|
BQ
|
88.75
|
2.96
|
TABLET
|
0
|
TAB
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
20120412
|
DIRECT THROMBIN INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
B1511
|
PRADAX 75MG TAB (BOE) DABIGATRAN (BQ)
|
DABIGATRAN
|
PRADAX
|
3X10
|
BQ
|
96.64
|
3.2212
|
TAB
|
60
|
BOX
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
20120412
|
DIRECT THROMBIN INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DIRECT THROMBIN INHIBITORS
|
|
|
|
|
40
|
B1521
|
PRADAX 110MG TAB (BOE/STO) DABIGATRAN
|
DABIGATRAN
|
PRADAX
|
3X10
|
BQ
|
88.75
|
2.96
|
TABLET
|
0
|
TAB
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
20120412
|
DIRECT THROMBIN INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
B1521
|
PRADAX 110MG TAB (BOE) DABIGATRAN (BQ)
|
DABIGATRAN
|
PRADAX
|
3X10
|
BQ
|
96.64
|
3.2212
|
TAB
|
60
|
BOX
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
20120412
|
DIRECT THROMBIN INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DIRECT THROMBIN INHIBITORS
|
|
|
|
|
40
|
B1524
|
PRADAX 110MG TAB (BOE/STO) DABIGATRAN
|
DABIGATRAN
|
PRADAX
|
60'S
|
BQ
|
177.51
|
2.96
|
TABLET
|
0
|
TAB
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
20120412
|
DIRECT THROMBIN INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
B1524
|
PRADAX 110MG TAB (BOE) DABIGATRAN (BQ)
|
DABIGATRAN
|
PRADAX
|
60'S
|
BQ
|
193.27
|
3.2212
|
TAB
|
60
|
BOX
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
20120412
|
DIRECT THROMBIN INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DIRECT THROMBIN INHIBITORS
|
|
|
|
|
40
|
B1531
|
PRADAX 150MG TAB (BOE/STO) DABIGATRAN
|
DABIGATRAN
|
PRADAX
|
60'S
|
BQ
|
177.51
|
2.96
|
TABLET
|
0
|
TAB
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
20120412
|
DIRECT THROMBIN INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
B1531
|
PRADAX 150MG TAB (BOE) DABIGATRAN (BQ)
|
DABIGATRAN
|
PRADAX
|
60'S
|
BQ
|
193.27
|
3.2212
|
TAB
|
60
|
BOX
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
20120412
|
DIRECT THROMBIN INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DIRECT THROMBIN INHIBITORS
|
|